Get the app
US › Healthcare

Claritev Corporation (CTEV)

US · Healthcare · Health Information Services

$31.73-5.45%
Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue
$257.5M
Revenue YoY
+6.6%
Net profit
$-59.2M
EPS
$-3.49
EPS estimate
$-4.10
Net margin
-23.0%

EPS came in at -3.49 against a street estimate of -4.10 — a beat of 14.9%.

Key statistics

Market cap
$609.8M
Forward P/E
4.9
P/B
43.86
Book value
$-17.39
EPS (TTM)
$-17.00
52-week high
$73.68
52-week low
$11.50
50-day MA
$32.35
200-day MA
$28.10
Beta
0.89

Analyst view

Analysts rate Claritev Corporation a buy (1 buy, 1 hold, 0 sell out of 2) with an average price target of $45.83.

Shareholding

Insiders
7.30%
Institutions
90.20%

Largest institutional holders

FundStake
H&F Corporate Investors VIII, Ltd.22.94%
Ares Management LLC10.99%
Arini Captial Management Ltd9.06%
PUBLIC INVESTMENT FUND7.56%
Beach Point Capital Management LP4.55%
BlackRock Inc3.47%
CPV Partners, LLC2.92%
Vanguard Capital Management, LLC2.54%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Claritev Corporation — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncMerck & Company IncUnitedHealth Group IncorporatedNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncNovo Nordisk A/SGilead Sciences IncAbbott Laboratories

Data updated 2026-09-18.